TOLREMO therapeutics

TOLREMO therapeutics AG is an ETH spinoff focused on the discovery and development of small molecules to prevent resistance in cancer therapy.

Raised

$9.3M

Follow us

Also headquartered in Zurich

Companies in the same industry

Alexa global traffic share

Twitter followers

Built with ❤︎ by Datalicious ©2022
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

24 Sep 2018

$9,300,000

Venture capital (Series A)